Last reviewed · How we verify
NCT07032935
The Effect of Virtual Reality Glasses on Vital Signs and State Anxiety in Patients Undergoing Coronary Angiography
NA trial testing Virtual Reality Glasses will be used DURING CORONARY ANGIOGRAPHY APPLICATION in Coronary Angiography (CAG) in 84 participants. Completed in 15 August 2025.
15 August 2025
Quick facts
| Lead sponsor | Kutahya Health Sciences University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 84 |
| Start date | 15 July 2025 |
| Primary completion | 15 August 2025 |
| Estimated completion | 15 August 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Virtual Reality Glasses will be used DURING CORONARY ANGIOGRAPHY APPLICATION
Conditions studied
- Coronary Angiography (CAG) — all drugs for Coronary Angiography (CAG) →
Sponsor
Kutahya Health Sciences University
Who can join
Adults 18 to 70, any sex, with Coronary Angiography (CAG). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Virtual reality (VR) glasses are an effective non-pharmacological method for reducing anxiety, supported by a high level of evidence and associated with no known side effects. Techniques involving relaxation and distraction, such as VR, function by suppressing the sympathetic branch of the autonomic nervous system and activating the parasympathetic branch, thereby eliciting a relaxation response. VR glasses divert the patient's attention away from pain and anxiety. By reducing the sense of unfamiliarity in clinical environments, VR helps patients adapt more easily, leading to enhanced relaxation. This state of relaxation not only alleviates anxiety but also induces favorable physiological responses. These include reductions in blood pressure (BP), heart rate (HR), and respiratory rate (RR), along with an increase in peripheral oxygen saturation (SpO₂). Additionally, the psychological benefits of VR contribute to the reduction of anxiety, stress, fear, and worry. VR is considered a cost-effective, safe, and non-pharmacological intervention. Several studies support its efficacy. For example, in a study comparing the effects of video games played through VR headsets and iPads on preoperative anxiety in adult patients undergoing sternotomy, anxiety was measured using the Depression Anxiety Stress Scale (DASS), and lower anxiety levels were observed in the VR group. Another study demonstrated that watching nature scenes through VR glasses for five minutes prior to maxillofacial surgery significantly reduced anxiety. Furthermore, research comparing progressive muscle relaxation exercises and VR during arthroscopic knee surgery-measured using the State Anxiety Inventory-indicated that both non-pharmacological interventions were effective in reducing anxiety. However, despite this growing body of evidence, no study to date has examined the effects of VR applications on anxiety in patients undergoing coronary angiography or pacemaker implantation. This study aims to fill that gap by investigating the comparative effectiveness of virtual reality applications in reducing anxiety in patients undergoing coronary angiography.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07032935
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Kutahya Health Sciences University trials
Trials by the same sponsor.
- NCT07522658 — Artificial Intelligence-Generated vs Academician-Developed Multiple True/False Questions in Anesthesiology Education · not yet recruiting
- NCT07536685 — THE TURKISH VERSION OF THE EKSTEROCEPTIVE BODY AWARENESS QUESTIONNAIRE · enrolling by invitation
- NCT07501416 — High-Intensity Laser Therapy in Hemiplegic Shoulder Pain · NA · not yet recruiting
- NCT07504887 — Effects of Aerobic Exercise in Rheumatoid Arthritis · NA · not yet recruiting
- NCT07460193 — CBCT and Audiological Analysis of the TMJ-Tinnitus Relationship · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07032935 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kutahya Health Sciences University
- Last refreshed: 3 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07032935.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing